Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Ramage

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Immunology, Immunotherapy : CII|February 18, 2006
Complement decay accelerating factor (DAF)/CD55 in cancerIan Spendlove, Judith M Ramage, Richard Bradley, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2006
The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2Judith M Ramage, Ian Spendlove, Robert Rees, et al.
Vaccine|April 8, 2004
Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic miceJudith M Ramage, Rachael Metheringham, Robert Moss, et al.
American Journal of Clinical Oncology|July 8, 2026
Single-Cell Transcriptomic Analysis Reveals γδ T-Cell Infiltration and Presence of Immune Regulatory Molecules in Biliary Tract Cancer MicroenvironmentSaikat Mandal, Stuart Astbury, Jane I Grove, et al.
European Journal of Immunology|December 30, 2009
DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+ T cellsVictoria A Pudney, Rachael L Metheringham, Barbara Gunn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2013
CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotypeRuhcha V Sutavani, Richard G Bradley, Judith M Ramage, et al.
Cancers|October 29, 2025
Epigenetic Regulation of Immune Responses in Endocrine-Related Cancers and Its Role in ImmunotherapyEvren M Akyuz, Meryem Gultekin, Judith M Ramage, et al.
Breast Cancer Research and Treatment|November 27, 2018
Connexin 43 is an independent predictor of patient outcome in breast cancer patientsMaria Chasampalioti, Andrew R Green, Ian O Ellis, et al.
Oncoimmunology|July 30, 2016
SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockadeWei Xue, Rachael L Metheringham, Victoria A Brentville, et al.
International Journal of Cancer|July 9, 2005
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosisNicholas F S Watson, Judith M Ramage, Zahra Madjd, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|February 18, 2006
Complement decay accelerating factor (DAF)/CD55 in cancerIan Spendlove, Judith M Ramage, Richard Bradley, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2006
The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2Judith M Ramage, Ian Spendlove, Robert Rees, et al.
Vaccine|April 8, 2004
Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic miceJudith M Ramage, Rachael Metheringham, Robert Moss, et al.
American Journal of Clinical Oncology|July 8, 2026
Single-Cell Transcriptomic Analysis Reveals γδ T-Cell Infiltration and Presence of Immune Regulatory Molecules in Biliary Tract Cancer MicroenvironmentSaikat Mandal, Stuart Astbury, Jane I Grove, et al.
European Journal of Immunology|December 30, 2009
DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+ T cellsVictoria A Pudney, Rachael L Metheringham, Barbara Gunn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2013
CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotypeRuhcha V Sutavani, Richard G Bradley, Judith M Ramage, et al.
Cancers|October 29, 2025
Epigenetic Regulation of Immune Responses in Endocrine-Related Cancers and Its Role in ImmunotherapyEvren M Akyuz, Meryem Gultekin, Judith M Ramage, et al.
Breast Cancer Research and Treatment|November 27, 2018
Connexin 43 is an independent predictor of patient outcome in breast cancer patientsMaria Chasampalioti, Andrew R Green, Ian O Ellis, et al.
Oncoimmunology|July 30, 2016
SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockadeWei Xue, Rachael L Metheringham, Victoria A Brentville, et al.
International Journal of Cancer|July 9, 2005
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosisNicholas F S Watson, Judith M Ramage, Zahra Madjd, et al.
Pageof 2